Pfizer Corporate Filings & Announcements

Latest corporate announcements and filings from Pfizer on BSE

Search Inside the pdf :

Pfizer Ltd.

29 Dec 2025

4849.30

0.90%

SAST

Pfizer Ltd - 500680 - Closure of Trading Window

BSE India

This is to inform you that the trading window for trading in shares of the Company shall remain closed from Wednesday, December 31, 2025 (close of business) till 48 hours after the financial results are made public.

pdf

Pfizer Ltd.

28 Dec 2025

4849.30

0.90%

Corp. Note

Pfizer Ltd - 500680 - Disclosure under Regulation 30A of LODR

BSE India

Intimation pursuant to Regulation 30 of SEBI LODR regarding receipt of an order levying penalty from GST Authorities.

pdf

Pfizer Ltd.

24 Dec 2025

4849.30

0.90%

Company Update

Pfizer Ltd - 500680 - Intimation Pursuant To Regulation 30 Of The SEBI (Listing Obligations And …

BSE India

Intimation pursuant to Regulation 30 of SEBI LODR regarding receipt of an order levying penalty from GST Authorities.

pdf

Pfizer Ltd.

23 Dec 2025

4849.30

0.90%

Company Update

Pfizer Ltd - 500680 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Intimation regarding change in Senior Management Personnel of the Company - Resignation of Ms. Aditi Mehta - Category Lead, Vaccines.

pdf

Pfizer Ltd.

19 Dec 2025

4849.30

0.90%

Company Update

Pfizer Ltd - 500680 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release in respect of an exclusive Supply & Marketing Arrangement with Cipla Limited for certain brands.

pdf

Pfizer Ltd.

19 Dec 2025

4849.30

0.90%

Company Update

Pfizer Ltd - 500680 - Exclusive Supply And Marketing Agreement With Cipla Limited For Certain Products.

BSE India

Exclusive Supply and Marketing Arrangement with Cipla Limited for Pfizer Limited''s Brands Corex Dx, Corex LS, Dolonex and Neksium.

pdf

Pfizer Ltd.

12 Nov 2025

4849.30

0.90%

Board Meeting

Pfizer Ltd - 500680 - Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial …

BSE India

Pursuant to Regulations 30 and 33 of the Listing Regulations, we submit herewith the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2025, which were inter alia approved by the Board of Directors of the Company at their Meeting held today i.e., November 12, 2025, that commenced at 2.00 p.m. and concluded at 3.15 p.m.

pdf

Pfizer Ltd.

03 Nov 2025

4849.30

0.90%

Board Meeting

Pfizer Ltd - 500680 - Board Meeting Intimation for Board Meeting To Consider And Approve The …

BSE India

Pfizer Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve This is to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, November 12, 2025 inter alia, to consider, approve and take on record the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2025.

pdf